The Carlyle Group LP  

(Public, NASDAQ:CG)   Watch this stock  
Find more results for CG
34.05
+0.55 (1.64%)
After Hours: 34.27 +0.22 (0.65%)
Jul 22, 6:24PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 33.56 - 34.34
52 week 24.66 - 39.38
Open 33.69
Vol / Avg. 213,820.00/389,370.00
Mkt cap 2.18B
P/E 18.44
Div/yield 0.16/5.52
EPS 1.85
Shares 64.09M
Beta     -
Inst. own 65%
Jul 30, 2014
Q2 2014 Carlyle Group LP Earnings Release - 9:30AM EDT - Add to calendar
Jul 30, 2014
Q2 2014 Carlyle Group LP Earnings Call - 8:30AM EDT - Add to calendar
Jun 4, 2014
Carlyle Group LP at KBW Asset Management Conference
Apr 30, 2014
Q1 2014 The Carlyle Group LP Earnings Release
Apr 30, 2014
Q1 2014 Carlyle Group LP Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 39.78% 30.35%
Operating margin 4.22% 16.83%
EBITD margin - 47.60%
Return on average assets 5.09% 4.01%
Return on average equity 11.98% 11.02%
Employees 1,500 -
CDP Score - -

Address

C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON, DC 20004
United States - Map
+1-202-7295626 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The Carlyle Group L.P. is a global alternative asset management firm. The Company advises an array of specialized investment funds and other investment vehicles that invest across a range of industries, geographies, asset classes and investment strategies. The Company conducts its operations through four segments: Corporate Private Equity, Real Assets, Global Market Strategies and Fund of Funds Solutions. Its Corporate Private Equity segment advises the Company�s buyout and growth capital funds. The Real Assets segment advises the Company�s United States and internationally-focused real estate and infrastructure funds, as well as its energy and renewable resources funds. Effective June 2, 2014, The Carlyle Group LP acquired an undisclosed majority interest in Talent Partners Inc. In July 2014, Johnson & Johnson completed the divestiture of Ortho-Clinical Diagnostics business to Carlyle Group.

Officers and directors

Daniel A. D' Aniello Chairman of the Board, Founder of Carlyle Group Management L.L.C.
Age: 67
Bio & Compensation  - Reuters
Michael J. Cavanagh Co-President, Co-Chief Operating Officer of Carlyle Group Management L.L.C.
Age: 48
Bio & Compensation  - Reuters
Glenn A. Youngkin Co-President, Co-Chief Operating Officer of Carlyle Group Management L.L.C.
Age: 47
Bio & Compensation  - Reuters
William E. Conway Jr Co-Chief Executive Officer, Founder, Director of Carlyle Group Management L.L.C.
Age: 64
Bio & Compensation  - Reuters
David M. Rubenstein Co-Chief Executive Officer, Founder, Director of Carlyle Group Management L.L.C.
Age: 64
Bio & Compensation  - Reuters
Daniel F. Akerson Vice Chairman of Carlyle Group Management L.L.C.
Age: 65
Bio & Compensation  - Reuters
Curtis L. Buser Interim Chief Financial Officer of Carlyle Group Management L.L.C.
Age: 50
Bio & Compensation  - Reuters
Pamela L. Bentley Chief Accounting Officer of Carlyle Group Management L.L.C.
Age: 42
Bio & Compensation  - Reuters
Jeffrey W. Ferguson General Counsel of Carlyle Group Management L.L.C.
Age: 48
Bio & Compensation  - Reuters
Edward J. Mathias Managing Director, Director of General partner
Bio & Compensation  - Reuters